Phylogenetic Analysis of HA and NA Genes of Influenza A Viruses in Immunosuppressed Inpatients in Beijing During the 2018-2020 Influenza Seasons

Overview

Journal Virol J

Publisher Biomed Central

Specialty Microbiology

Date 2023 May 26

PMID 37237356

Authors

Yafen Liu

Yue Wang

Yanxin Wang

Huan Mai

Yuanyuan Chen

Yifan Zhang

Ying Ji

Xu Cong

Yan Gao

Affiliations

Soon will be listed here.

Abstract

Background: Influenza A viruses have undergone rapid evolution with virulent; however, complete and comprehensive data on gene evolution and amino acid variation of HA and NA in immunosuppressed patients was few. In this study, we analysed molecular epidemiology and evolution of influenza A viruses in immunosuppressed population, and immunocompetent population were used as controls.

Methods: Full sequences of HA and NA of A(H1N1)pdm09 and A(H3N2) were acquired through reverse transcription-polymerase chain reaction (RT-PCR). HA and NA genes were sequenced using the Sanger method and phylogenetically analysed using ClustalW 2.10 and MEGA software version 11.0.

Results: During the 2018-2020 influenza seasons, 54 immunosuppressed and 46 immunocompetent inpatients screened positive for influenza A viruses by using the quantitative real-time PCR (qRT-PCR) were enrolled. 27 immunosuppressed and 23 immunocompetent nasal swab or bronchoalveolar lavage fluid samples were randomly selected and sequenced using the Sanger method. A(H1N1)pdm09 were detected in 15 samples and the remaining 35 samples were A(H3N2) positive. By analyzing the HA and NA gene sequences of these virus strains, we found that all A(H1N1)pdm09 viruses shared high similarities to each other and the HA and NA genes of these viruses exclusively belonged to subclade 6B.1A.1. Some NA genes of A(H3N2) viruses were not in the same clade as those of A/Singapore/INFIMH-16-0019/2016 and A/Kansas/14/2017, which may have led to A(H3N2) being the dominant strain in the 2019-2020 influenza season. Both A(H1N1)pdm09 and A(H3N2) viruses showed similar evolutionary lineages patterns of HA and NA between immunosuppressed and immunocompetent patients. Compared with the vaccine strains, there were no statistically significant of HA and NA genes and amino acid sequences of influenza A viruses in immunosuppressed and immunocompetent patients. However, the oseltamivir resistance substitution of NA-H275Y and R292K have been observed in immunosuppressed patients.

Conclusions: A(H1N1)pdm09 and A(H3N2) viruses showed similar evolutionary lineages patterns of HA and NA between immunosuppressed and immunocompetent patients. Both immunocompetent and immunosuppressed patients have some key substitutions, which should be of note monitored, especially those with potential to affect the viral antigen.

References

LHuillier A, Abed Y, Petty T, Cordey S, Thomas Y, Bouhy X . E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient. J Infect Dis. 2015; 212(11):1726-34. PMC: 4633758. DOI: 10.1093/infdis/jiv288. View

Kunisaki K, Janoff E . Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis. 2009; 9(8):493-504. PMC: 2775097. DOI: 10.1016/S1473-3099(09)70175-6. View

. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ. 2013; 346:f3039. PMC: 3668094. DOI: 10.1136/bmj.f3039. View

Wedde M, Biere B, Wolff T, Schweiger B . Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany. Int J Med Microbiol. 2015; 305(7):762-75. DOI: 10.1016/j.ijmm.2015.08.030. View

Kuzmanovska M, Boshevska G, Janchevska E, Buzharova T, Simova M, Peshnacka A . A Comprehensive Molecular and Epidemiological Characterization of Influenza Viruses Circulating 2016-2020 in North Macedonia. Front Microbiol. 2021; 12:713408. PMC: 8567633. DOI: 10.3389/fmicb.2021.713408. View

Liu B, Wang Y, Liu Y, Chen Y, Liu Y, Cong X . Molecular evolution and characterization of hemagglutinin and neuraminidase of influenza A(H1N1)pdm09 viruses isolated in Beijing, China, during the 2017-2018 and 2018-2019 influenza seasons. Arch Virol. 2020; 166(1):179-189. DOI: 10.1007/s00705-020-04869-z. View

Zurcher T, Yates P, Daly J, Sahasrabudhe A, Walters M, Dash L . Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro. J Antimicrob Chemother. 2006; 58(4):723-32. DOI: 10.1093/jac/dkl321. View

Liu M, Deng L, Wang D, Jiang T . Influenza activity during the outbreak of coronavirus disease 2019 in Chinese mainland. Biosaf Health. 2020; 2(4):206-209. PMC: 7462755. DOI: 10.1016/j.bsheal.2020.08.005. View

Gooskens J, Jonges M, Claas E, Meijer A, van den Broek P, Kroes A . Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. JAMA. 2009; 301(10):1042-6. DOI: 10.1001/jama.2009.297. View

10.

Mitnaul L, Matrosovich M, Castrucci M, Tuzikov A, Bovin N, Kobasa D . Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol. 2000; 74(13):6015-20. PMC: 112098. DOI: 10.1128/jvi.74.13.6015-6020.2000. View

11.

Fang Q, Gao Y, Chen M, Guo X, Yang X, Yang X . Molecular epidemiology and evolution of A(H1N1)pdm09 and H3N2 virus during winter 2012-2013 in Beijing, China. Infect Genet Evol. 2014; 26:228-40. DOI: 10.1016/j.meegid.2014.05.034. View

12.

Miron V, Banica L, Sandulescu O, Paraschiv S, Surleac M, Florea D . Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season. PLoS One. 2021; 16(11):e0258798. PMC: 8589178. DOI: 10.1371/journal.pone.0258798. View

13.

Smith G, Vijaykrishna D, Bahl J, Lycett S, Worobey M, Pybus O . Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009; 459(7250):1122-5. DOI: 10.1038/nature08182. View

14.

Pascalis H, Temmam S, Wilkinson D, Dsouli N, Turpin M, de Lamballerie X . Molecular evolutionary analysis of pH1N1 2009 influenza virus in Reunion Island, South West Indian Ocean region: a cohort study. PLoS One. 2012; 7(8):e43742. PMC: 3428279. DOI: 10.1371/journal.pone.0043742. View

15.

Baz M, Abed Y, Simon P, Hamelin M, Boivin G . Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J Infect Dis. 2010; 201(5):740-5. DOI: 10.1086/650464. View

16.

Memoli M, Athota R, Reed S, Czajkowski L, Bristol T, Proudfoot K . The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis. 2013; 58(2):214-24. PMC: 3871797. DOI: 10.1093/cid/cit725. View

17.

Air G . Influenza neuraminidase. Influenza Other Respir Viruses. 2011; 6(4):245-56. PMC: 3290697. DOI: 10.1111/j.1750-2659.2011.00304.x. View

18.

Kim M, Kweon O, Lim Y, Choi S, Chung J, Lee M . Impact of social distancing on the spread of common respiratory viruses during the coronavirus disease outbreak. PLoS One. 2021; 16(6):e0252963. PMC: 8202938. DOI: 10.1371/journal.pone.0252963. View

19.

Rambaut A, Pybus O, Nelson M, Viboud C, Taubenberger J, Holmes E . The genomic and epidemiological dynamics of human influenza A virus. Nature. 2008; 453(7195):615-9. PMC: 2441973. DOI: 10.1038/nature06945. View

20.

Siegers J, Dhanasekaran V, Xie R, Deng Y, Patel S, Ieng V . Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020. J Virol. 2021; 95(24):e0126721. PMC: 8610588. DOI: 10.1128/JVI.01267-21. View